EPIQ Capital Group LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
EPIQ Capital Group LLC
CRD #292526
SEC #801-112887
CIK #0001779453
AUM
Employees 60 (53% Investors, 0% Brokers)
Fees
Minimum
Phone415-433-3747
Address1 Lombard St 200
San Francisco, CA 94111
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
5.04.03.02.01.00.02009201420192025
Fees and Compensation — Form ADV Part 2A (10/9/2024) [Brochure]
ITEM 5: Fees & Compensation

Advisory & Other Fees We Charge

Depending on circumstances, clients or investors pay us different types of fees, including:

        Advisory fees
        Management fees
        Performance‐based incentive fees (i.e., “carry”)
        Service fees

Each of these fee types and the circumstances to which they apply are described more fully below.

     Advisory Fees

     Client advisory fee schedules are negotiated on a client‐by‐client basis and are determined based upon a number
     of factors including, but not limited to, the amount and type of work involved, the services offered, the size of the
     portfolios and the amount of our resources dedicated to providing the services. Investment advisory fees based on
     assets under management are billed on a pro‐rata, annualized basis, quarterly in arrears, based on the average daily
     balance of the client portfolio for the quarter. Clients generally pay an annual fee of up to a maximum of 1.5% of
     assets under management. In some cases, the advisory fee includes a minimum quarterly amount or fees for
     administration of investments that are not advised on by us. In addition, some clients have flat fee structures that
     are not based on assets under management.

     Generally, client billable investments include only those accounts and investments authorized in a Client Direction
     Letter. Clients may request a copy of an Advisory Scope report from their client team, which details the
     investments that they have approved on a Client Direction Letter and on which we bill. Advisory fees may be
     modified by us upon notice to clients.

     Our firm or a client may terminate our agreement at any time by providing a written thirty (30) day notice to the
     other party. After notice of termination has been received, our firm will continue to charge its advisory fees to a
     client up to and including the actual date of termination.

6                                                                   EPIQ Capital Group, LLC  |  Form ADV Part 2A: Firm Brochure

     Investment Management Fees

     Investors who do not have an advisory relationship with EPIQ generally pay a management fee of up to 1.5%
     annually of the aggregate value of their interest in the Vehicle. Any Vehicle management fee is waived for clients
     who maintain an advisory relationship with our firm under which they are paying advisory fees discussed above.
     The management fee is documented in each Vehicle’s constituent documents or in a side letter agreement with the
     investor paying the management fee. EPIQ has the right to waive the management fee for any client or investor in
     its discretion.
Account Minimums and Types of Clients — Form ADV Part 2A (10/9/2024) [Brochure]
ITEM 7: Types of Clients & Account Requirements

Our firm has the following types of clients:

        High Net Worth Individuals (“HNW Individuals”),
        Trusts, Estates or Charitable Organizations associated with HNW Individuals,
        Retirement Accounts of HNW Individuals, and
        Corporations, Limited Liability Companies and/or Other Business Types associated with HNW Individuals.

Our firm generally requires clients to have a minimum of $50 million in investable assets. This requirement may be waived at
our discretion on a client‐by‐client basis based on our understanding of a prospective client’s overall financial position and
potential asset base.
Sector Form 13F Holdings Value ($M)
Reddit Inc 26.7
iShares Comex Gold Trust 26.3
Facebook Inc 20.3
SPDR Gold Trust 16.8
Rubrik Inc 13.5
Applovin Corp 12.8
Apple Inc 4.5
Alibaba Group Holding Ltd 3.5
JDcom Inc 2.6
Datadog Inc 2.4
View All
Holdings by Sector ($M)
100080060040020002020202220242026
Type Form D Funds Date Sold AUM
PE EPQ LLC DGNR VI PS [2023-03-31] 52.0 M
Filed 2021-08-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Antios B PS [2022-03-30]
Filed 2021-09-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Applvn PS [2022-03-30]
Filed 2021-03-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Ltest PS [2022-03-30]
Filed 2021-01-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Owlet PS [2022-03-30]
Filed 2021-02-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Transform III PS [2022-03-30] 40.0 M
Filed 2022-01-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC AMTC PS [2021-03-30] 35.0 M 0.5 M
Offered $35,000,000 · Filed 2020-06-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Lcovd PS [2021-03-30]
Filed 2020-07-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC Lcovd Safe PS [2021-03-30]
Filed 2020-11-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE EPQ LLC LFLU PS [2021-03-30] 17.5 M
Offered $17,500,000 · Filed 2020-01-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 234 2.8
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 86 2.1
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 896 4.9
By Discretionary
Discretionary 647 2.7
Non-Discretionary 249 2.3
Total 896 4.9
By Non-United States Persons
Non-United States Persons 0.1
United States Persons 4.9
Total 896 4.9
Form D Directors Role # Filings # Firms 2011 - 2026
Epiq Capital Group LLC Director 110 3
Epiq Capital Group LLC Director 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001779453]
3 [0001779453]
4 [0001779453]
5 [0001779453]
SC 13D [0001779453]
Form 13D/13G Filer Form 13D/13G Subject Filed
EPIQ Capital Group LLC Lucira Health Inc [2021-02-12]
EPIQ Capital Group LLC Applied Molecular Transport Inc [2020-06-18]
Firm Profile (Form ADV)
ServesInstitutional, Retail
Fund TypesPrivate Equity
Form 3/4/5 Subject 2011 - 2026
EPIQ Capital Group LLC
Boeding Chad
EPQ LLC AMTC PS
EPQ LLC AMTB PS
EPQ LLC AMT PS
Applied Molecular Transport Inc
EPQ LLC Lcovd PS
Lucira Health Inc
EPQ LLC Ltest PS
EPQ LLC Lcovd Safe PS
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Applied Molecular Transport Inc AMTI
Common Stock
2023-12-27 Other 293,278
Applied Molecular Transport Inc AMTI
Common Stock
2023-12-27 Other 2,149,292
Applied Molecular Transport Inc AMTI
Common Stock
2023-12-27 Other 3,394,948
Applied Molecular Transport Inc AMTI
Common Stock
2023-12-27 Other 2,500,000
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 3,461,764
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 735,475
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 725,675
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 3,754,084
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 5,173,026
Lucira Health Inc LHDX
Common Stock
2022-12-14 Other 256,742
Applied Molecular Transport Inc AMTI
Common Stock
2022-05-13 Buy 29,763 $4.17 124,112
Applied Molecular Transport Inc AMTI
Common Stock
2022-05-12 Buy 32,380 $3.88 125,634
Applied Molecular Transport Inc AMTI
Common Stock
2021-11-17 Buy 7,135 $22.38 159,681
Applied Molecular Transport Inc AMTI
Common Stock
2021-11-16 Buy 4,000 $22.57 90,280
Lucira Health Inc LHDX
Series B Convertible Preferred · derivative
2021-02-05 Conversion 32,176
Lucira Health Inc LHDX
Common Stock
2021-02-05 Conversion 735,475 $17.00 12,503,075
Lucira Health Inc LHDX
Common Stock
2021-02-05 Conversion 3,754,084
Lucira Health Inc LHDX
Common Stock
2021-02-05 Conversion 32,176
Lucira Health Inc LHDX
Common Stock
2021-02-05 Buy 3,461,764 $17.00 58,849,988
Lucira Health Inc LHDX
Common Stock
2021-02-05 Conversion 5,173,026
showing 20 of 45 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com